Tinnitus is the perception of sound without an external source, often considered a phantom percept similar to phantom limb sensations, resulting from maladaptive plasticity in the brain. The condition lacks an established biomarker for diagnosis but recent studies have linked it to neural changes....
No actionable change yet — this is a published study protocol; results are pending and no validated tinnitus biomarker is currently available for clinical use.
Identifying an objective biomarker for chronic tinnitus would be transformative for diagnosis, clinical trial design, and personalised treatment in a condition that currently relies entirely on self-report.
- 01TIDE project protocol published in BMJ Open to identify objective biomarkers for chronic tinnitus.
- 02Study uses a data-driven, personalised approach to biomarker identification and validation.
- 03Currently no objective diagnostic test exists for tinnitus — all diagnosis is self-reported.
- 04Biomarker validation could enable more rigorous tinnitus clinical trials in the future.
- 05This is a protocol paper only; clinical findings have not yet been reported.
A data-driven, personalised approach can identify and validate objective biomarkers for chronic tinnitus diagnosis.
studyunclearThere is currently no objective biomarker available for diagnosing chronic tinnitus.
opinionsupported- PMID
- 42156141
- DOI
- 10.1136/bmjopen-2025-112788.
- Journal
- BMJ Open
- Publication type
- research_article
- Evidence level
- na
- Population
- Adults with chronic tinnitus (protocol stage; subjects not yet enrolled/reported)
- Intervention
- Data-driven personalised biomarker identification and validation for chronic tinnitus
Primary outcomes
Identification of objective biomarkers for chronic tinnitus; Validation of biomarker diagnostic accuracy